Release Therapeutics SA (RTx) is a Swiss biotech company developing the first intracerebral encapsulated cell technology (ECT) platform for the treatment of severe genetic disorders of the central nervous system (CNS).
- https://release-tx.com/
- Send an email
- Professor Nicolas Mach
Some insights
Our dedicated team brings together tremendous experience developing novel therapies from bench to bedside and has been instrumental in the evolution of cell macroencapsulation technology, from ideation to a potentially life-transforming reality.
